---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-033482"
form_type: "8-K"
ticker: "CYCU"
cik: "0001868419"
company_name: "Cycurion, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:27:31.763914+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Western Acquisition Ventures Corp. receives Nasdaq delisting notice due to entire board resignation

## Summary
- Nasdaq notified WAVS on March 11, 2024 of non-compliance with Listing Rule 5605(b)(1) after entire board resigned effective December 27, 2023.
- Resigning directors: Stephen Christoffersen, William Lischak, Ade Okunabi, Robin Smith, and Adam Stern.
- Company must regain compliance by the earlier of next annual meeting or December 28, 2024; if meeting before June 25, 2024, then by June 25, 2024.
- Failure to cure within the period will result in Nasdaq staff issuing a delisting notice.
- Company is actively working to regain compliance with Nasdaq’s independent board and committee requirements.

## SEC filing metadata
- accession: 0001104659-24-033482
- form_type: 8-K
- ticker: CYCU
- cik: 0001868419
- company_name: Cycurion, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868419/000110465924033482/0001104659-24-033482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868419/000110465924033482/tm248583-1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-033482
- JSON: https://secwatch.observer/filing/0001104659-24-033482.json
- Plain text: https://secwatch.observer/filing/0001104659-24-033482.txt

## Key facts
- Listing & Compliance Notices
  Cycurion, Inc. received a nasdaq deficiency notice notice regarding other (rules 5605(b)(1), 5605(b)(1)(A), 5810(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: 5605(b)(1), 5605(b)(1)(A), 5810(b)
  source text: which was previously reported in a current report on Form 8-K filed with the Securities and Exchange Commission on January 3, 2024, the Company no longer complies with Nasdaq’s Majority Independent Board rule, its Audit Committee Rule, or its Compensation Committee Rule as set forth in Listing Rule 5605(b)(1). In accordance with Nasdaq Listing Rule 5605(b)(1)(A), Nasdaq will provide the Company a cure period in order to regain compliance as follows: (i) until the earlier of the Company’s next annual stockholders’ meeting or December 28, 2024; or (ii) if the Company’s next annual stockholders’
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868419/000110465924033482/0001104659-24-033482-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.